Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Hany Chidiac is an experienced regenerative medicine physician specializing in male health, anti-aging, and cellular wellness treatments
Part of it is weight [loss], but other factors may be contributing as well better glycemic controls, anti-inflammatory effects. More research is necessary and inevitable especially studies looking at the newer weight-loss formulations of GLP-1 medications, says Benjamin Liu, another resident physician at Case Western and co-author of the ASCO study
Having prediabetes also is associated with an increased risk for heart disease, stroke, eye problems, neuropathy (nerve damage), and kidney disease
Many of these categories have strong emotional or habitual relevance and with the right product reformulations focused on flavor balance, nutritional content, portion control and better textures, there is tremendous opportunity to reinvigorate these categories for the GLP-1 consumer. According to a 2024 KFF Health Tracking Poll cited in the IFF report, 12% of US adults have been on a GLP-1 medication at least once in their lives, while 6% of US adults are currently on a GLP-1 drug
US$ 27.02
US$ 23.63
US$ 27.17
US$ 20.41
US$ 27.61
